Postpartum estrogen withdrawal impairs GABAergic inhibition and LTD induction in basolateral amygdala complex via down-regulation of GPR30

Eur Neuropsychopharmacol. 2017 Aug;27(8):759-772. doi: 10.1016/j.euroneuro.2017.05.010. Epub 2017 Jun 13.

Abstract

Postpartum estrogen (E2) withdrawal is known to be a particularly vulnerable time for depressive symptoms. In this study, ovariectomized (OVX) mice were treated with co-administration of estradiol benzoate and progesterone (E2/P4) followed by administration of E2 alone (E2) and a subsequent E2 withdrawal (EW) to mimic the hormonal changes during pregnancy and postpartum. The objective of this study was to investigate the influence of E2 withdrawal after hormone-simulated pregnancy on synaptic function and plasticity in basolateral amygdala complex (BLA). In comparison to control mice, EW mice spent less time in the central portion of open-field test and open arms of elevated plus-maze. Excitatory postsynaptic potentials (EPSPs) slopes at external capsule BLA synapse were reduced in E2/P4-mice, recovered in E2-mice, and increased in EW-mice. EW-mice showed a significant increase in duration of EPSPs and paired-pulse inhibition (PPI) with multi-spike responses of EPSPs and impairment of long-term depression (LTD) induction, which were corrected by GABAAR agonist muscimol. Levels of estrogen receptor (ER) GPR30, ERα and ERβ expression in BLA of EW-mice were lower than those in control mice. The bath-application of GPR30 agonist G-1 in BLA of EW-mice recovered the GABAAR-mediated inhibition and LTD indication, but ERβ agonist DPN or ERα agonist PPT could not. A single BLA-injection of G-1 rather than DPN or PPT in EW-mice could partially relieve the anxiety-like behaviors. The results indicate that postpartum E2 withdrawal causes dysfunction of GABAAR-mediated inhibition in the BLA through reducing GPR30 expression, which impairs LTD induction and causes anxiety-like behaviors.

Keywords: E2 withdrawal (EW), basolateral amygdala complex (BLA); G-protein-coupled estrogen receptor 30 (GPR30); Hormone-simulated pregnancy (HSP); Postpartum depression (PPD).

MeSH terms

  • Animals
  • Basolateral Nuclear Complex / drug effects
  • Basolateral Nuclear Complex / physiology*
  • Contraceptive Agents / pharmacology
  • Down-Regulation*
  • Estradiol / analogs & derivatives
  • Estradiol / pharmacology
  • Estrogens / metabolism*
  • Evoked Potentials / drug effects
  • Female
  • GABA-A Receptor Agonists / pharmacology
  • Long-Term Synaptic Depression / drug effects
  • Long-Term Synaptic Depression / genetics
  • Long-Term Synaptic Depression / physiology*
  • Mice
  • Mice, Inbred ICR
  • Muscimol / pharmacology
  • Ovariectomy
  • Postpartum Period / physiology
  • Progesterone / pharmacology
  • Progestins / pharmacology
  • Receptors, Estrogen / genetics*
  • Receptors, G-Protein-Coupled / genetics*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Substance Withdrawal Syndrome / pathology
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • Contraceptive Agents
  • Estrogens
  • GABA-A Receptor Agonists
  • GPER1 protein, mouse
  • Progestins
  • Receptors, Estrogen
  • Receptors, G-Protein-Coupled
  • estradiol 3-benzoate
  • Muscimol
  • Progesterone
  • Estradiol
  • gamma-Aminobutyric Acid